| 1 |
Targeted gene knockout mediated by triple helix forming oligonucleotides
Alokes Majumdar, Alexander A. Khorlin, Natalia B. Dyatkina et al. · Nature Genetics
|
Oct 1998 |
149 |
| 2 |
Identification of a Novel Mammary-Restricted Cytochrome P450, CYP4Z1, with Overexpression in Breast Carcinoma
Michael A. Rieger, Reinhard Ebner, David Bell et al. · Cancer Research
|
Apr 2004 |
111 |
| 3 |
A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome
Donald L. Gilbert, Cathy L. Budman, Harvey S. Singer et al. · Clinical Neuropharmacology
|
2014 |
106 |
| 4 |
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study
Donald L. Gilbert, Tanya K. Murphy, Joseph Jankovic et al. · Movement Disorders
|
Aug 2018 |
85 |
| 5 |
Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity
Won Jun Choi, Hwa‐Jin Chung, Girish Chandra et al. · Journal of Medicinal Chemistry
|
23 Apr 2012 |
71 |
| 6 |
Requirement of hCenexin for Proper Mitotic Functions of Polo-Like Kinase 1 at the Centrosomes
Nak‐Kyun Soung, Young Hwi Kang, Keetae Kim et al. · Molecular and Cellular Biology
Open access |
Nov 2006 |
68 |
| 7 |
Real-World Experience With VMAT2 Inhibitors
Nicki Niemann, Joseph J. Jankovic · Clinical Neuropharmacology
|
Mar 2019 |
51 |
| 8 |
Clavulanic acid: A competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects
Deog J. Kim, Jean Anne King, Lisa A. Zuccarelli et al. · Pharmacology Biochemistry and Behavior
|
25 Apr 2009 |
47 |
| 9 |
The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2
Dzjemma Sarkisjan, Joris R. Julsing, Kees Smid et al. · PLoS ONE
Open access |
9 Sep 2016 |
46 |
| 10 |
Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
Young Bok Lee, Young‐Dae Gong, Heejeong Yoon et al. · Bioorganic & Medicinal Chemistry
|
20 Sep 2010 |
42 |
| 11 |
A Novel Anti‐Cancer Agent, 1‐(3,5‐Dimethoxyphenyl)‐4‐[(6‐Fluoro‐2‐Methoxyquinoxalin‐3‐yl)Aminocarbonyl] Piperazine (RX‐5902), Interferes With β‐Catenin Function Through Y593 Phospho‐p68 RNA Helicase
Gina Chun Kost, Mi Yang, Liangwei Li et al. · Journal of Cellular Biochemistry
|
3 Feb 2015 |
41 |
| 12 |
Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360)
Godefridus J. Peters, Kees Smid, Leonardo Vecchi et al. · Investigational New Drugs
|
17 Sep 2013 |
38 |
| 13 |
RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment
Beatrice Balboni, Btissame El Hassouni, Richard J. Honeywell et al. · Expert Opinion on Investigational Drugs
Open access |
16 Mar 2019 |
36 |
| 14 |
First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer
Anna Capasso, Stacey M. Bagby, Kyrie L. Dailey et al. · Molecular Cancer Therapeutics
Open access |
5 Sep 2019 |
34 |
| 15 |
A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease
Tanya Khasnavis, Rosa J. Torres, Barbara Sommerfeld et al. · Molecular Genetics and Metabolism
|
30 Apr 2016 |
34 |
| 16 |
A Double-blind, Placebo-Controlled Study of the Impact of Galantamine on Anterograde Memory Impairment During Electroconvulsive Therapy
John Matthews, Caleb J. Siefert, Mark A. Blais et al. · Journal of Ect
|
22 Mar 2013 |
34 |
| 17 |
Clavulanic acid increases dopamine release in neuronal cells through a mechanism involving enhanced vesicle trafficking
Gina Chun Kost, Senthil Selvaraj, Young Bok Lee et al. · Neuroscience Letters
Open access |
22 Sep 2011 |
34 |
| 18 |
In vivo and in vitro effects of a HIF‐1α inhibitor, RX‐0047
Z. Günnur Dikmen, Ginelle C. Gellert, Pakıze Doğan et al. · Journal of Cellular Biochemistry
Open access |
14 Feb 2008 |
34 |
| 19 |
Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents
Suhui Yang, Hue Thi My Van, Thanh Nguyen Le et al. · Bioorganic & Medicinal Chemistry Letters
|
4 Jul 2010 |
30 |
| 20 |
Lipid–Albumin Nanoparticles (LAN) for Therapeutic Delivery of Antisense Oligonucleotide against HIF-1α
Hong Li, Jishan Quan, Mengzi Zhang et al. · Molecular Pharmaceutics
|
2 Jun 2016 |
28 |
| 21 |
On-Demand Continuous Manufacturing of Ciprofloxacin in Portable Plug-and-Play Factories: Development of a Highly Efficient Synthesis for Ciprofloxacin
Cameron T. Armstrong, Yuma Miyai, Anna Formosa et al. · Organic Process Research & Development
|
25 Jun 2021 |
27 |
| 22 |
Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells
Gina Chun Kost, Senthil Selvaraj, Young Bok Lee et al. · Brain Research
Open access |
30 Jun 2012 |
26 |
| 23 |
Antitumor activity of a novel antisense oligonucleotide against Akt1
Heejeong Yoon, Deog Joong Kim, Eun Hyun Ahn et al. · Journal of Cellular Biochemistry
Open access |
19 Aug 2009 |
26 |
| 24 |
Development of 3-aryl-1-isoquinolinamines as potent antitumor agents based on CoMFA
Suhui Yang, Hue Thi My Van, Thanh Nguyen Le et al. · European Journal of Medicinal Chemistry
|
25 Aug 2010 |
26 |
| 25 |
Synthesis and evaluation of naphthyridine compounds as antimalarial agents
Shuren Zhu, Quan Zhang, Gudise Chandrashekar et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
17 Sep 2007 |
25 |
| 26 |
A novel cytidine analog, RX-3117, shows potent efficacy in xenograft models, even in tumors that are resistant to gemcitabine.
Mi Young Yang, Young Bok Lee, Chang‐Ho Ahn et al. · PubMed
|
Dec 2014 |
20 |
| 27 |
Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
Young Bok Lee, Young‐Dae Gong, Deog Joong Kim et al. · Bioorganic & Medicinal Chemistry
|
27 Dec 2011 |
20 |
| 28 |
A clinical trial of safety and tolerability for the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease
Tanya Khasnavis, Gail Reiner, Barbara Sommerfeld et al. · Molecular Genetics and Metabolism
|
20 Feb 2016 |
18 |
| 29 |
Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide
Hong Li, Yang Liu, Lihua Chen et al. · Journal of drug targeting
|
29 Jan 2018 |
17 |
| 30 |
A Single-Blind Study of ‘As-Needed’ Ecopipam for Gambling Disorder
Jon Edgar Grant, Brian L. Odlaug, Donald W. Black et al. · Annals of Clinical Psychiatry
|
Aug 2014 |
17 |
| 31 |
Aliphatic and Alicyclic Diols Induce Melanogenesis in Cultured Cells and Guinea Pig Skin
David Alexander Brown, Wu‐Yun Ren, Alexander A. Khorlin et al. · Journal of Investigative Dermatology
Open access |
Apr 1998 |
17 |
| 32 |
Cognitive Task Performance and Frequency of Alcohol Usage in Young Adults
Arit M. Harvanko, Brian L. Odlaug, Liana R. N. Schreiber et al. · Journal of Addiction Medicine
|
26 Nov 2011 |
15 |
| 33 |
QSID Tool: a new three-dimensional QSAR environmental tool
Dong Sun Park, Jae Min Kim, Young Bok Lee et al. · Journal of Computer-Aided Molecular Design
|
29 May 2008 |
15 |
| 34 |
RX-3117 (Fluorocyclopentenyl-Cytosine)-Mediated Down-Regulation of DNA Methyltransferase 1 Leads to Protein Expression of Tumor-Suppressor Genes and Increased Functionality of the Proton-Coupled Folate Carrier
Dzjemma Sarkisjan, Joris R. Julsing, Btissame El Hassouni et al. · International Journal of Molecular Sciences
Open access |
14 Apr 2020 |
12 |
| 35 |
Bicyclic Monoterpene Diols Induce Differentiation of S91 Melanoma and PC 12 Pheochromocytoma Cells by a Cyclic Guanosine‐Monophosphate‐Dependent Pathway
David Alexander Brown, Krystyna B. Lesiak, Wu‐Yun Ren et al. · Pigment Cell Research
|
Feb 1999 |
10 |
| 36 |
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma
Hani M. Babiker, Peter J. Schlegel, Lee G. Hicks et al. · Investigational New Drugs
|
21 Aug 2021 |
6 |
| 37 |
The radiosensitizing effect of fluorocyclopentenyl-cytosine (RX-3117) in ovarian and lung cancer cell lines
Dzjemma Sarkisjan, Jaap van den Berg, Evelyn Smit et al. · Nucleosides Nucleotides & Nucleic Acids
Open access |
Dec 2016 |
5 |
| 38 |
Novel Mycophenolic Adeninebis(Phosphonate)S as Potent Anticancer Agents and Inducers of Cells Differentiation
Krzysztof W. Pankiewicz, Krystyna B. Lesiak-Watanabe · Nucleosides and Nucleotides
|
Apr 1999 |
5 |
| 39 |
Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder
Robert A. Riesenberg, Joshua Rosenthal, Leslie Moldauer et al. · Psychopharmacology
|
27 Dec 2011 |
2 |
| 40 |
Formation and Reactivity of 2,4-Ditriazolyl Pyrimidine C-Nucleoside Derived from Pseudouridine
Natalia B. Dyatkina, Alexander A. Khorlin, Kyoichi A. Watanabe · Nucleosides Nucleotides & Nucleic Acids
|
Mar 2000 |
2 |
| 41 |
4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder
Tanya K. Murphy, Donald L. Gilbert, Cathy L. Budman et al. · Journal of the American Academy of Child & Adolescent Psychiatry
|
Oct 2017 |
1 |
| 42 |
Synthesis of Methylenebis(Phosphonate) Analogues of Nucleotide Coenzymes. A Novel Coupling Mechanism
Krzysztof W. Pankiewicz, Krystyna B. Lesiak, Kyoichi A. Watanabe · Phosphorus, sulfur, and silicon and the related elements
|
1999 |
1 |
| 43 |
RX-3117, a Novel Nucleoside Analog Targeting UCK2 Is Active Alone and Synergistic with Ibrutinib and Bendamustine in ABC and DH/DP- Diffuse Large B-Cell Lymphoma
Shariful Islam, Umar Nazir Zahid, Laurence S. Cooke et al. · Blood
|
7 Dec 2017 |
0 |
| 44 |
International Conference on Nucleic Acid Medical Applications, NAMA Conference
Matthews O. Bradley, Rushdi Alul, Purshotam Bhan · Antisense Research and Development
|
1993 |
0 |
| 45 |
Interim Analysis of an Open-Label, Multi-Center Study of Ecopipam, a Dopamine D1 Receptor Antagonist, for Tic Reduction in Adults with Tourette Syndrome (P02.058)
Donald L. Gilbert, Cathy L. Budman, Harvey S. Singer et al. · Neurology
|
12 Feb 2013 |
0 |